Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fanny Valleix"'
Autor:
Yutaro Kaneko, Ryo Hatano, Naoto Hirota, Nicolas Isambert, Véronique Trillet-Lenoir, Benoit You, Jérôme Alexandre, Gérard Zalcman, Fanny Valleix, Thomas Podoll, Yoshimi Umezawa, Seiichi Takao, Satoshi Iwata, Osamu Hosono, Tetsuo Taguchi, Taketo Yamada, Nam H. Dang, Kei Ohnuma, Eric Angevin, Chikao Morimoto
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-13 (2021)
Abstract Background The phase I trial of the humanized anti-CD26 monoclonal antibody YS110 for CD26-expressing tumors was conducted recently. The present study identifies a potential prognostic biomarker for CD26-targeted therapy based on the phase I
Externí odkaz:
https://doaj.org/article/869532e7d9924a45b065a8c40a83cd05
Autor:
Fanny Valleix, Tetsuo Taguchi, Benoit You, Yutaro Kaneko, Thomas Podoll, Naoto Hirota, Nicolas Isambert, Kei Ohnuma, Ryo Hatano, Gérard Zalcman, Nam H. Dang, Eric Angevin, Véronique Trillet-Lenoir, Seiichi Takao, Yoshimi Umezawa, Taketo Yamada, Chikao Morimoto, Osamu Hosono, Satoshi Iwata, Jérôme Alexandre
Publikováno v:
Biomarker Research
Biomarker Research, Vol 9, Iss 1, Pp 1-13 (2021)
Biomarker Research, Vol 9, Iss 1, Pp 1-13 (2021)
Background The phase I trial of the humanized anti-CD26 monoclonal antibody YS110 for CD26-expressing tumors was conducted recently. The present study identifies a potential prognostic biomarker for CD26-targeted therapy based on the phase I data. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ce65814344ffa433e56209cace7b82
https://doi.org/10.21203/rs.3.rs-126614/v1
https://doi.org/10.21203/rs.3.rs-126614/v1
Autor:
Gérard Zalcman, Nicolas Isambert, Philippe Viehl, Itaru Miyashita, Nam H. Dang, Jérôme Alexandre, Benoit You, Yutaro Kaneko, Osamu Hosono, Eric Angevin, Françoise Farace, Kei Ohnuma, Véronique Trillet-Lenoir, Yu Kuramochi, Taketo Yamada, Chikao Morimoto, Fanny Valleix, Thomas Podoll
Publikováno v:
Journal of Clinical Oncology. 33:2519-2519
2519 Background: YS110 is a recombinant humanized IgG1 monoclonal antibody that selectively binds with high affinity to the extracellular domain of the CD26 antigen. Preclinical evaluations of YS11...
Autor:
Masami Kuriyama, Fanny Valleix, Ken-ichi Yamada, Kazushige Nagai, Takahiro Soeta, Kiyoshi Tomioka
Publikováno v:
ChemInform. 36
The copper–amidophosphane-catalyzed asymmetric addition reaction of dialkylzinc reagents with β-aryl and β-alkylnitroalkenes afforded the corresponding nitroalkanes with moderate to good enantioselectivities (54–80% ee). The performance was hig
Autor:
Y. Kaneko, Jérôme Alexandre, Fanny Valleix, Taketo Yamada, Chikao Morimoto, Itaru Miyashita, Eric Angevin, Thomas Podoll, Nicolas Isambert, Véronique Trillet-Lenoir
Publikováno v:
Annals of Oncology. 23:ix170-ix171
Background YS110 is a recombinant humanized IgG1 monoclonal antibody that selectively binds with high affinity to the extracellular domain of the CD26 antigen. CD26, a widely distributed 110-kDa transmembrane glycoprotein with intrinsic DPPIV activit
Publikováno v:
HETEROCYCLES. 55:2273
The preparation of piperidine- and pyrrolidinone-like polymer supported (R)-phenylglycinol derived scaffolds is described. Alkylation reactions were performed as a model transformation of these templates on the solid support which highlight some spec